Verity Asset Management, Inc. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
Verity Asset Management, Inc. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$2,125,449
+33.7%
40,593
+3.8%
0.83%
-6.0%
Q1 2024$1,590,141
+50.3%
39,089
+36.5%
0.89%
+31.4%
Q4 2023$1,058,091
-11.5%
28,628
-8.6%
0.68%
-23.4%
Q3 2023$1,196,042
+29.7%
31,310
+22.5%
0.88%
+28.8%
Q2 2023$922,274
-23.0%
25,569
-18.4%
0.68%
-4.3%
Q1 2023$1,197,371
-20.8%
31,353
+18.0%
0.72%
-44.7%
Q4 2022$1,512,118
-99.9%
26,575
-16.7%
1.29%
-0.6%
Q3 2022$1,260,852,000
+100848.9%
31,888
+1.9%
1.30%
+63.9%
Q1 2022$1,249,000
-13.2%
31,296
-12.6%
0.79%
-6.6%
Q4 2021$1,439,000
+17.0%
35,797
+18.4%
0.85%
+6.6%
Q3 2021$1,230,000
+22.4%
30,241
+36.6%
0.80%
+44.6%
Q2 2021$1,005,000
+24.8%
22,135
+14.6%
0.55%
+14.8%
Q1 2021$805,000
+1.5%
19,310
+4.0%
0.48%
-13.2%
Q4 2020$793,000
+52.8%
18,575
-5.9%
0.55%
+40.0%
Q3 2020$519,000
-12.5%
19,743
-10.7%
0.40%
-27.8%
Q2 2020$593,000
+38.2%
22,106
-7.3%
0.55%
+1.1%
Q1 2020$429,000
-18.6%
23,852
-19.8%
0.54%
+3.0%
Q4 2019$527,000
+10.0%
29,737
-3.7%
0.52%
+4.6%
Q3 2019$479,000
-11.0%
30,871
-1.5%
0.50%
-16.9%
Q2 2019$538,000
+55.0%
31,329
+45.3%
0.60%
+50.6%
Q1 2019$347,000
+16.8%
21,569
+6.2%
0.40%
+0.8%
Q4 2018$297,000
+89.2%
20,313
+24.6%
0.40%
+163.6%
Q4 2014$157,00016,3020.15%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$206,177,00028.12%
BB BIOTECH AG 8,322,860$121,763,0003.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 398,633$4,579,0002.84%
DOHENY ASSET MANAGEMENT /CA 227,193$3,324,0002.43%
SNYDER CAPITAL MANAGEMENT L P 2,833,759$41,458,0002.24%
First Light Asset Management, LLC 938,399$13,729,0002.19%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,027,164$132,067,0001.77%
Taylor Wealth Management Partners 204,277$2,989,0001.72%
Sterling Global Strategies LLC 22,000$321,860,0001.63%
Granite Investment Partners, LLC 988,939$14,468,0001.06%
View complete list of HALOZYME THERAPEUTICS INC shareholders